GTx and Oncternal Therapeutics Enter into Definitive Merger Agreement to Create Nasdaq-Listed Clinical-Stage Company Developing a Diverse Pipeline of Novel Cancer Therapies

GTx, Inc. to Host Fourth Quarter and Full Year 2015 Financial Results Conference Call and Webcast

GTx, Inc. To Host Third Quarter 2015 Financial Results Conference Call and Webcast

GTx, Inc. To Host Second Quarter 2015 Financial Results Conference Call and Webcast

GTx and the University of Tennessee Research Foundation Enter Into Exclusive License Agreement to Develop UTRF’s SARD Drug Technology

GTx, Inc. to Host Fourth Quarter and Full Year 2014 Financial Results Conference Call and Webcast

GTx, Inc. To Host Third Quarter 2014 Financial Results Conference Call and Webcast

GTx, Inc. To Host Fourth Quarter and Full Year 2013 Financial Results Conference Call and Webcast